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. Geometries of the most representative structures obtained from the cluster analysis of the 75-100 ns section of the 302.8 K REMD trajectory of Mets7
Experimental Materials and Methods
Solvents, reagents were purchased from commercial sources. All peptides were purified using RP-HPLC and a C-18 column (10 µm, 250 22 mm). ESI mass spectra were recorded on a LCQ Advantage spectrometer.
Synthesis of Fmoc-protected scaffold 4
The Fmoc-protected compound 4 was synthesized in solution starting from the known compound
1.
6 (Scheme S1). Hydrogenolysis of 1 was performed in toluene affording free amino compound 2 (99%). The ester function was hydrolyzed in acidic conditions yielding compound 3 (99%).
Finally, the Fmoc group was introduced using Fmoc-OSu, in the presence of DIPEA and MeOH/ACN affording 4 (72%). [α] Operating in a sealed tube, compound 2 (0.1 g; 0.262 mmol) was dissolved in 6M HCl (10 mL) and heated at 110°C under stirring. After 4 h, the solvent was removed. The crude precipitated was taken up with acetone and a white solid was filtered (95 mg, 99 %).
1-[(3R,4R)-4-(4-Methylphenylsulfonamido)piperidin-3-yl]-pyrrolidine-2-(S)-carboxylic

Acid (3)
[α] [α] Regarding peptide S1, the coupling of 4 (1.5 eq) was performed on the peptide growing chain linked to rink-amide resin using HOBT and HBTU (1.5 eq) and DIPEA (3 eq), and standing the mixture under shaking overnight.
Compounds Mets7, A, B, B1, C, S1 and AlaScan were finally acetylated on resin using Ac2O (10 eq) and DIPEA (10 eq). The cleavage was then performed using reagent K 14 (trifluoroacetic acid/phenol/water/thioanisole/1,2-ethanedithiol; 82. General procedure for Henry reaction. 8 A mixture of peptide-Cu(I) complex (5 mol %, 0.05 eq), t-BuOH (1 mL) and either CH3NO2 (1 mL) in a screw capped vial-2 mL was stirred at room temperature for 1.5 h. Then aldehyde (1 eq) was added to the above solution. The resulting reaction mixture was stirred for 12 h at 40 °C. Afterwards, 1N HCl was added to quench the reaction and then the volatiles were evaporated by rotavapor to get crude product. The conversion was determined by 1 H-NMR and the enantiomeric excess by HPLC analysis. All reactions were carried out for 12 h using 5 mol % complex in 2 mL of mixture solvent.
[a]
Conversion was obtained by 1 H-NMR analysis.
[b]
Data were compared by taking the average of three independent experiments. Enantiomeric excess was determined using HPLC equipped with chiral OD-H column. Eluent: hexane/2-propanol=90/10 flow=1.0 mL/min, λ = 215 nm.
[sub]f = 10 mM, [cat]f = 0.45 mM.
13
NMR data and discussion for peptide S1
All experiments ( 1 H, COSY, TOCSY, and ROESY) were recorded in H2O/D2O 90:10 (9.6 mM)
at 500 MHz.
Compound S1 is present in solution as a mixture of cis/trans rotamers of the tertiary amide on the piperidine ring. In particular, the signals of Met-1 and Met-4 are double, while Met-6 are single ( Figure FS3 ), confirming the higher mobility of the peptide chain linked to the piperidine ring due to the rotation of the tertiary amide bond. 
Circular Dichroism and UV experiments
Solutions of peptides Mets7, A, B, B1, C, S1 and their Cu(I) complexes were prepared in H2O
(100 µM, 1.5 mL). CD spectra were obtained from 195 to 250 nm with a 0.1 nm step and 1 s collection time per step, taking three averages. The spectrum of the solvent was subtracted to eliminate interference from cell, solvent, and optical equipment. The CD spectra were plotted as mean residue ellipticity θ (degree x cm 2 x dmol -1 ) versus wave length λ (nm). Noise-reduction was obtained using a Fourier-transform filter program. 
